Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Intensive care medicine 2015-02, Vol.41 (2), p.371-372
Hauptverfasser:	Asensio, M. J., Sánchez, M., Galván, B., Herrero, E., Cachafeiro, L., Agrifoglio, A., Perales, E., Luque, S., García-de-Lorenzo, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anesthesiology Antifungal Agents - administration & dosage Antifungal Agents - blood Antifungal Agents - therapeutic use Burns Burns - complications Burns - drug therapy Burns and scalds Candidiasis, Invasive - drug therapy Caspofungin Critical Care Critical Care Medicine Critical Illness Drug dosages Echinocandins - administration & dosage Echinocandins - blood Echinocandins - therapeutic use Emergency Medicine Female Health aspects Humans Infections Intensive Intensive care Letter Lipopeptides - administration & dosage Lipopeptides - blood Lipopeptides - therapeutic use Male Medicine Medicine & Public Health Middle Aged Mortality Pain Medicine Patients Pediatrics Pharmacokinetics Plasma Plasma physics Pneumology/Respiratory System Wound Infection - drug therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!